Literature DB >> 23711978

A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats.

A C Oakly1, B W Brox1, S Schenk1, B A Ellenbroek1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23711978     DOI: 10.1038/mp.2013.75

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  12 in total

Review 1.  MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity.

Authors:  Susan Schenk
Journal:  Neurosci Biobehav Rev       Date:  2010-12-22       Impact factor: 8.989

2.  The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls.

Authors:  Jonathan P Roiser; Robert D Rogers; Lynnette J Cook; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2006-08-29       Impact factor: 4.530

3.  Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.

Authors:  Katharine A Brennan; Caleb Carati; Rod A Lea; Paul S Fitzmaurice; Susan Schenk
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

4.  Fluoxetine reduces intravenous cocaine self-administration in rats.

Authors:  M E Carroll; S T Lac; M Asencio; R Kragh
Journal:  Pharmacol Biochem Behav       Date:  1990-01       Impact factor: 3.533

5.  In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat.

Authors:  Michael H Baumann; Robert D Clark; William L Woolverton; Sunmee Wee; Bruce E Blough; Richard B Rothman
Journal:  J Pharmacol Exp Ther       Date:  2011-01-12       Impact factor: 4.030

6.  3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.

Authors:  José Manuel Trigo; Thibault Renoir; Laurence Lanfumey; Michel Hamon; Klaus-Peter Lesch; Patricia Robledo; Rafael Maldonado
Journal:  Biol Psychiatry       Date:  2007-02-16       Impact factor: 13.382

7.  The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.

Authors:  A P Leccese; W H Lyness
Journal:  Brain Res       Date:  1984-06-11       Impact factor: 3.252

8.  Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system.

Authors:  J R Homberg; J D A Olivier; B M G Smits; J D Mul; J Mudde; M Verheul; O F M Nieuwenhuizen; A R Cools; E Ronken; T Cremers; A N M Schoffelmeer; B A Ellenbroek; E Cuppen
Journal:  Neuroscience       Date:  2007-04-30       Impact factor: 3.590

9.  Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats.

Authors:  Yann Pelloux; Ruth Dilleen; Daina Economidou; David Theobald; Barry J Everitt
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  18 in total

1.  Intravenous self-administration of entactogen-class stimulants in male rats.

Authors:  Sophia A Vandewater; Kevin M Creehan; Michael A Taffe
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

2.  Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats.

Authors:  S M Aarde; P K Huang; T J Dickerson; M A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2014-11-26       Impact factor: 4.530

3.  Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms.

Authors:  Ross van de Wetering; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2017-02-10       Impact factor: 4.530

4.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.

Authors:  Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2015-05-01       Impact factor: 4.530

5.  Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.

Authors:  Dane Aronsen; Natasha Bukholt; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2016-02-09       Impact factor: 4.530

6.  3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats.

Authors:  Holly S Hake; Jazmyne K P Davis; River R Wood; Margaret K Tanner; Esteban C Loetz; Anais Sanchez; Mykola Ostrovskyy; Erik B Oleson; Jim Grigsby; Rick Doblin; Benjamin N Greenwood
Journal:  Physiol Behav       Date:  2018-12-04

7.  Median and Dorsal Raphe Serotonergic Neurons Control Moderate Versus Compulsive Cocaine Intake.

Authors:  Michel M M Verheij; Candice Contet; Peter Karel; Judith Latour; Rick H A van der Doelen; Bram Geenen; Josephus A van Hulten; Francisca Meyer; Tamas Kozicz; Olivier George; George F Koob; Judith R Homberg
Journal:  Biol Psychiatry       Date:  2017-11-20       Impact factor: 13.382

8.  A genetic reduction in the serotonin transporter differentially influences MDMA and heroin induced behaviours.

Authors:  Bridget W Brox; Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2018-03-21       Impact factor: 4.530

9.  "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.

Authors:  Sean B Dolan; Zhenglan Chen; Renqi Huang; Michael B Gatch
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

10.  Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats.

Authors:  Quenten Highgate; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2018-09-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.